Diabetic patients can use the Freestyle Libre sensor to continuously monitor their glucose levels on a smartphone app. Photograph: BSIP/Universal Images Group via Getty ImagesUS medtech giant Abbott Laboratories is investing €440 million in Ireland with plans for a major new manufacturing plant in Kilkenny and additional jobs in Donegal.
After an initial scan, the sensor sends a glucose reading every minute to a smartphone app. The app will show that current glucose level, a trend arrow showing how your glucose level is changing and plot your last six hours of glucose readings in graph format. The app can also issue alarms if glucose levels are too low or too high. Each sensor lasts for 14 days.
“We work well with the IDA and they were instrumental in finding a suitable site for us here in Kilkenny,” Mr Watkin said. “And we have had an outstanding experience with the Irish workforce … which means it is a sensible strategic investment for us to keep going back there.” Ireland, it says, is the only country in western Europe to reimburse by age rather than clinical need.
“Abbott has a long and successful history [in Ireland] and this new investment is a great vote of confidence in the workforce here, and in this country as a place to invest,” he said.
Excellent news. (Shinners won’t be happy, but who cares what they think?)
Ireland Ireland Latest News, Ireland Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimesBiz - 🏆 6. / 77 Read more »